Comparison of the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay for detection of high-risk human papillomavirus in women with abnormal PAP smear
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 147 (1) , 10-17
- https://doi.org/10.1016/j.jviromet.2007.07.023
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay in Detection of High-Risk Human Papillomavirus and Diagnosis of Biopsy-Confirmed High-Grade Cervical DiseaseJournal of Clinical Microbiology, 2007
- Detection and genotyping of human papillomavirus in cervical samples from Italian patientsJournal of Medical Virology, 2005
- Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessmentCancer, 2004
- Human Papillomavirus Testing with the Hybrid Capture 2 Assay and PCR as Screening ToolsJournal of Clinical Microbiology, 2004
- Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 2004
- Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up studyBMJ, 2002
- Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are ReproducibleJournal of Clinical Microbiology, 2002
- Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 womenBritish Journal of Cancer, 2001
- HPV testing in primary screening of older womenBritish Journal of Cancer, 1999
- Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal WomenThe Journal of Infectious Diseases, 1994